2020-11-16T15:51:02-06:00 2020-06-30 930900579 MCDONALD JACOBS PC 520 SW YAMHILL ST STE 500 PORTLAND OR 97204 990 2019-07-01 930571472 NATIONAL PSORIASIS FOUNDATION NATI 5032447404 6600 SW 92ND AVENUE NO 300 PORTLAND OR 97223 RANDY BERANEK PRESIDENT/CEO 5032447404 2020-11-12 1 SANG AHN P00540880 5032270581 50.204.228.78 2020-11-12 16:30:39 PS P DA39A3EE5E6B4B0D3255BFEF95601890AFD80709 B2CE5BFF6E3FDEC0016682CF93CFC2B94EF6ACF0 2019 2021-01-29 14:40:06Z RANDY BERANEK 6600 SW 92ND AVENUE NO 300 PORTLAND OR 97223 16027266 0 X WWW.PSORIASIS.ORG X 1968 OR TO DRIVE EFFORTS TO CURE PSORIATIC DISEASE AND IMPROVE THE LIVES OF THOSE AFFECTED. 19 19 87 4160 1443296 398703 13168307 12708368 1271782 1493367 137107 218630 -361942 -183715 14215254 14236650 2781813 3264997 0 0 5977319 6390459 0 0 2048615 4666505 4249222 13425637 13904678 789617 331972 12437744 14435005 3903740 5710733 8534004 8724272 X THE NATIONAL PSORIASIS FOUNDATION PROVIDES PEOPLE WITH PSORIASIS AND PSORIATIC ARTHRITIS THE SERVICES THEY NEED TO BEST MANAGE THEIR CONDITION, WHILE PROMOTING RESEARCH TO FIND A CURE. 0 0 4169934 3264997 0 RESEARCHPSORIATIC DISEASE RESEARCH ACCOUNTED FOR 31 PERCENT OF TOTAL EXPENSES FOR THE NATIONAL PSORIASIS FOUNDATION (NPF). THIS INCLUDED THE SUCCESSFUL LAUNCH AND AWARD OF THE PSORIASIS PREVENTION INITIATIVE (PPI) GRANT, WHICH FUNDS MULTI-INSTITUTIONAL, MULTI-DISCIPLINARY RESEARCH TEAMS WITH THE GOAL OF IDENTIFYING AN INTERVENTION THAT WILL PREVENT THE ONSET OF PSORIATIC DISEASE, DISEASE RELAPSE OR RELATED COMORBIDITIES. IN ADDITION, FUNDING CONTINUED FOR THE PSA DIAGNOSTIC TEST GRANT, THE MECHANISM SUPPORTING RESEARCH FOR THE DEVELOPMENT OF A ROBUST, RELIABLE AND REPRODUCIBLE CLINICAL DIAGNOSTIC TEST FOR PSORIATIC ARTHRITIS (PSA), A SIGNIFICANT UNMET NEED FOR THE COMMUNITY. RESEARCH FUNDING WAS ALSO PROVIDED FOR DISCOVERY EFFORTS, EARLY CAREER RESEARCHERS, TRANSLATIONAL SCIENCE AND FELLOWS AND STUDENT PROJECTS.SEVERAL OTHER RESEARCH INITIATIVES PROGRESSED, INCLUDING DEFINING REMISSION AND CURE, THE VALIDATION OF CITIZEN PSCIENTIST PATIENT REGISTRY PLATFORM AND PREPARATION FOR THE FIRST NPF-LED CLINICAL STUDY. NPF ALSO PARTNERED WITH UPENN IN A PATIENT CENTERED OUTCOMES RESEARCH INITIATIVE-FUNDED STUDY AIMING TO EVALUATE THE SAFETY AND EFFECTIVENESS OF HOME VERSUS OFFICE PHOTOTHERAPY. THIS UNIQUE STUDY WILL EVALUATE ALL SKIN TYPES AND INCLUDE SITES NATIONWIDE. FROM A PATIENT-CENTERED POINT OF VIEW, NPF MADE SIGNIFICANT ADVANCES IN ITS ANNUAL SURVEY, WHICH RESULTED IN MULTIPLE PUBLICATIONS ABOUT THE EXPERIENCE OF LIVING WITH PSORIATIC DISEASE AND CARE MANAGEMENT. THE JOURNAL OF PSORIASIS AND PSORIATIC ARTHRITIS (JPPA) ACHIEVED INITIAL INDEXING, WITH ORIGINAL RESEARCH AND OVERALL SUBMISSIONS INCREASING IN NUMBER AND CITATIONS ON THE RISE. 1203555 0 0 MEDICAL PROFESSIONAL EDUCATIONPROFESSIONAL EDUCATION IS A PILLAR OF THE FOUNDATION'S WORK TO OPTIMIZE CARE AND HEALTH OUTCOMES FOR THE PATIENT COMMUNITY. ALL THE NPF IN-PERSON MEDICAL EDUCATION PROGRAMS MOVED TO DIGITAL OR VIRTUAL PROGRAMS AFTER THE ONSET OF THE COVID-19 PANDEMIC, BUT THE OFFERINGS WERE STILL DIVERSE AND ENCOMPASSING. THERE WERE PROGRAMS FOR TRAINEES AND PROVIDERS ON A VARIETY OF TOPICS. THE RESIDENT'S MEETING, IN ITS 21ST YEAR, WAS WELL ATTENDED WITH AN OUTSTANDING FACULTY. NPF FOCUSED EFFORTS ON INCREASING THE COLLABORATION BETWEEN DERMATOLOGISTS AND RHEUMATOLOGISTS, WHICH IS ESSENTIAL TO IMPROVE THE DIAGNOSIS AND TREATMENT OF PSA. THE ADVANCE PRACTICE PSORIASIS RECOGNITION PROGRAM (A-PREP), WHICH IS SPECIFICALLY DESIGNED TO ADDRESS KNOWLEDGE AND PRACTICE GAPS AMONG PHYSICIAN ASSISTANTS AND NURSE PRACTITIONERS, WAS VERY WELL RECEIVED. THE PROGRAM COVERS PATHOPHYSIOLOGY, DIAGNOSIS AND ASSESSMENT OF PSORIASIS, APPROPRIATE THERAPIES AND TREATMENT GUIDELINES THROUGH DIDACTIC LECTURES, SPECIALIZED MODULES AND Q&AS. GRAND ROUNDS WERE HELD AT A VARIETY OF INSTITUTIONS TO PROMOTE LEARNING IN UNDERSERVED AREAS. IN ADDITION TO LIVE PROGRAMS, SEVERAL WEBINARS, PODCAST AND ENDURING CONTENT MATERIALS WERE CREATED TO ADDRESS THE MOST IMPORTANT ASPECTS OF PSORIATIC DISEASE RESEARCH AND CARE WITH EMPHASIS ON THE NEWLY RELEASED TREATMENT GUIDELINES. NPF ALSO INITIATED EFFORTS FOR A MEDICAL SCHOOL EDUCATION CURRICULUM RESOURCE TO INTRODUCE FIRST- AND SECOND-YEAR MEDICAL STUDENTS TO CONCEPTS AND CONSIDERATIONS FOR PSORIATIC DISEASE. THE PROGRAM WILL BE PROVIDED TO MEDICAL SCHOOLS ACROSS THE COUNTRY WITH THE HOPE OF BRINGING A GREATER AWARENESS TO ALL FUTURE PROVIDERS BUT ALSO TO ENGAGE MORE PHYSICIANS IN TRAINING FOR THE COMMUNITY. 1251397 0 0 ADVOCACYNPF WORKS TO ENSURE PATIENTS HAVE AFFORDABLE ACCESS TO THE TREATMENTS THEY NEED. THIS YEAR, THAT INCLUDED STEP THERAPY REFORM VICTORIES IN SOUTH DAKOTA, LOUISIANA AND NORTH CAROLINA, WHERE PATIENTS WILL NOW HAVE IMPROVED ACCESS TO CARE.NPF LEVERAGES ITS TENS OF THOUSANDS OF ADVOCATES TO WORK FOR HEALTH INSURANCE COVERAGE IMPROVEMENTS FOR THE MILLIONS OF PEOPLE IN THE U.S. LIVING WITH PSORIATIC DISEASE, WHILE ALSO WORKING TO IMPROVE THE SAFETY AND AFFORDABILITY OF PSORIASIS AND PSA TREATMENTS AND INCREASING FEDERAL FUNDING FOR PSORIATIC DISEASE RESEARCH. 3911424 0 51365 EDUCATION, OUTREACH AND PATIENT SERVICESNPF ADVANCE MAGAZINE CONTINUES TO PROVIDE THE LATEST INFORMATION, STORIES AND RESOURCES FOR 26,000 PRINT SUBSCRIBERS AND HUNDREDS OF THOUSANDS OF ONLINE READERS. THROUGH NPF'S PATIENT NAVIGATION CENTER, OVER 19,000 PATIENTS RECEIVED FREE, PERSONALIZED SUPPORT DESIGNED TO HELP THEM UNDERSTAND PSORIATIC DISEASE AND TREATMENT OPTIONS, NAVIGATE INSURANCE CHALLENGES AND FIND THE APPROPRIATE HEALTH CARE PROVIDER. NPF PROVIDED A COMPREHENSIVE SET OF EDUCATIONAL AND INFORMATIONAL RESOURCES TO THE OVER 5 MILLION VISITORS TO PSORIASIS.ORG AND ASSOCIATED SITES. EACH WEEK, MORE THAN 130,000 PEOPLE RECEIVED ADVANCE WEEKLY, THE OFFICIAL PATIENT-FOCUSED E-NEWSLETTER OF NPF.IN ITS SECOND YEAR, NPF'S PSOUND BYTES PODCAST RELEASED 51 DIVERSE EPISODES COVERING TOPICS LIKE UNDERSTANDING COVID-19'S INTERACTION WITH PSORIATIC DISEASE, ADVOCATING DIGITALLY AND UNDERSTANDING THE TRIGGERS AND FLARES OF PSORIATIC DISEASE.THROUGH TEAM NPF, MORE THAN 3,700 PEOPLE PARTICIPATED IN-PERSON OR VIRTUAL EVENT AS EITHER A PSTAMP OUT (BINGO), CYCLE, RUN, WALK OR DIY FUNDRAISER. 3911424 0 51365 10536310 1 1 0 1 0 0 0 0 0 0 1 0 0 0 1 1 1 0 0 0 0 1 0 0 1 0 0 1 0 1 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 1 83 0 87 1 1 1 0 0 0 0 1 1 0 0 0 0 0 0 X 19 19 0 0 0 0 0 0 0 1 1 0 0 1 1 1 1 1 1 1 1 0 AL AK AZ AR CA CO CT DE DC FL GA HI ID IL IN IA KS KY LA ME MD MA MI MN MS MO MT NE NV NH NJ NM NY NC ND OH OK OR PA RI SC SD TN TX UT VT VA WA WV WI WY X X JOHN ROGACKI 5032447404 6600 SW 92ND AVENUE NO 300 PORTLAND OR 97223 RAYMOND CHIP NEWTON CHAIR 1.00 X X 0 0 0 RON GRAU CHAIR-ELECT 1.00 X X 0 0 0 CAROL OSTROW VICE-CHAIR 1.00 X X 0 0 0 EYAL OFIR TREASURER 1.00 X X 0 0 0 RICHARD SEIDEN SECRETARY 1.00 X X 0 0 0 PETE REDDING DIRECTOR 1.00 X 0 0 0 APRIL ARMSTRONG MD DIRECTOR 1.00 X 0 0 0 MATTHEW T KISELICA DIRECTOR 1.00 X 0 0 0 KATHLEEN GALLANT DIRECTOR 1.00 X 0 0 0 PETE MILLER DIRECTOR 1.00 X 0 0 0 JASON LICHTEN MD DIRECTOR 1.00 X 0 0 0 MARK OBERMAN DIRECTOR 1.00 X 0 0 0 MICHAEL GRAFF DIRECTOR 1.00 X 0 0 0 ELAINE HUSNI MD DIRECTOR 1.00 X 0 0 0 JERRY BAGEL MD DIRECTOR 1.00 X 0 0 0 JODI WOOD DIRECTOR 1.00 X 0 0 0 MIKE REFERMAT DIRECTOR 1.00 X 0 0 0 LARRY GREEN MD DIRECTOR 1.00 X 0 0 0 RANDY BERANEK PRESIDENT/CEO 40.00 X 309022 0 28903 JOHN ROGACKI VP OF FINANCE & OPERATIONS 40.00 X 0 0 0 LEAH HOWARD CHIEF OPERATING OFFICER 40.00 X 202800 0 20833 EMILY BOYD CHIEF REVENUE OFFICER 40.00 X 190572 0 19797 STACY BELL VP OF RESEARCH & MEDICAL AFFAIRS 40.00 X 190000 0 27116 BRIDGET HART DIRECTOR OF MAJOR GIFTS 40.00 X 131333 0 19908 PATRICK STONE VP OF GOVERNMENT RELATIONS & ADVOCACY 40.00 X 122985 0 7119 KRISTINE BOCKMIER DIRECTOR OF FIELD OPERATIONS 40.00 X 117863 0 18223 DENICE BRADBURY DIRECTOR OF MARKETING & COMMUNICATIONS 40.00 X 106816 0 6255 1371391 0 148154 8 0 1 0 ROCKPOINTE CORPORATION 8335 GUILFORD ROAD SUITE A COLUMBIA MD 21046 CONTINUNG MEDICAL EDUCATION PROVIDER 625800 GMMB 3050 K STREET NW SUITE 100 WASHINGTON DC 20007 MARKETING CONSULTING 274294 PACIFIC MARKETING & PUBLISHING 2517 SE MAILWELL DR PORTLAND OR 97222 PRINTING 222246 FAEGRE DRINKER BIDDLE & REATH LLP 1050 K STREET NW SUITE 400 WASHINGTON DC 20001 CONSULTING 198813 LITHTEX PRINTING SOLUTIONS 6770 NW CENTURY BLVD HILLSBORO OR 97124 PRINTING 180175 5 73614 50664 2085990 10498100 766114 12708368 ADVERTISING INCOME 541800 1443296 1443296 CONSULTING 532000 50071 50071 1493367 216849 216849 1607388 1605607 1781 1781 1781 0 2085990 185009 -185009 -185009 1294 0 1294 1294 14236650 51365 1443296 33621 2284997 2284997 980000 980000 1215941 909488 88909 217544 4017811 3005205 293779 718827 217908 162989 15933 38986 546573 408821 39965 97787 392226 293374 28679 70173 87048 67496 7326 12226 23500 23500 448606 448606 36529 36529 1168759 823710 114591 230458 869722 315643 89892 464187 390882 197932 160276 32674 599068 422495 45082 131491 57568 43194 4004 10370 BAD DEBT 249390 16456 228162 4772 MISCELLANEOUS 214253 155904 39229 19120 TAXES 103897 103897 13904678 10536310 1319753 2048615 X 2916260 4485112 3244767 2866371 401037 337482 18573 14453 181795 265591 579945 409602 87637 170343 5557511 6265489 30164 30164 12437744 14435005 892661 1029652 2605000 3270000 39550 182500 366529 1228581 3903740 5710733 X 7167604 7256310 1366400 1467962 8534004 8724272 12437744 14435005 331972 -141704 0 X X 0 1 X 1 0 X 9161189 13602330 13408527 13168307 12708368 62048721 9161189 13602330 13408527 13168307 12708368 62048721 25219547 36829174 76192 62020 89858 124320 216849 569239 62617960 4756607 0.58820 0.63840 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 18486 430120 448606 11443986 11892592 744630 186158 0 0 684683 722412 711673 744630 2863398 4295097 415619 464205 430252 448606 1758682 171171 180603 177918 186158 715850 1073775 14388 14589 18486 47463 32132 20895 11237 243135 226442 16693 304678 162265 142413 170343 DEFERRED RENT 106834 GIFT ANNUITY LIABILITY 42011 DEFERRED COMPENSATION 24194 REFUNDABLE ADVANCE 1055542 1228581 X 14058417 -141704 -141704 14200121 36529 36529 14236650 13868149 0 13868149 36529 36529 13904678 PART X, LINE 2: THE ORGANIZATION FOLLOWS THE PROVISION OF FASB ASC TOPIC OF ACCOUNTING FOR UNCERTAINTY IN INCOME TAXES. MANAGEMENT HAS EVALUATED THE ORGANIZATION'S TAX POSITIONS AND CONCLUDED THAT THERE ARE NO UNCERTAIN TAX POSITIONS THAT REQUIRE ADJUSTMENT TO THE FINANCIAL STATEMENTS TO COMPLY WITH PROVISIONS OF THIS TOPIC. 1 0 0 0 0 0 0 0 0 0 UNITED KINGDOM DISCOVERY GRANT 75000 CHECK SWITZERLAND DISCOVERY GRANT 75000 WIRE CANADA DISCOVERY GRANT 75000 CHECK AUSTRALIA DISCOVERY GRANT 75000 CHECK SWEDEN DISCOVERY GRANT 75000 WIRE CANADA EARLY CAREER RESEARCH GRANT 50000 WIRE BELGIUM EARLY CAREER RESEARCH GRANT 50000 CHECK CANADA EARLY CAREER RESEARCH GRANT 50000 CHECK CANADA PSORIATIC ARTHRITIS DIAGNOSTIC TEST GRANT 100000 CHECK CANADA FELLOWSHIP 50000 CHECK ITALY TRANSLATIONAL RESEARCH GRANT - 1ST YEAR 100000 WIRE DENMARK TRANSLATIONAL RESEARCH GRANT - 1ST YEAR 100000 WIRE ENGLAND TRANSLATIONAL RESEARCH GRANT - 2ND YEAR 100000 WIRE 13 0 0 0 0 0 0 0 PART I, LINE 2: GRANT RECIPIENTS WITH MULTI-YEAR AWARDS PROVIDE INTERIM SCIENTIFIC AND PROGRESS REPORTS. ALL GRANT RECIPIENTS PROVIDE A FINAL SCIENTIFIC REPORT AND ACCOUNTING AT THE CONCLUSION OF THE RESEARCH TERM. THE INTERIM AND FINAL REPORTS ARE REVIEWED BY THE VP OF RESEARCH PROGRAMS OF THE NATIONAL PSORIASIS FOUNDATION. PART III ACCOUNTING METHOD: TEAM NPF 1725240 1725240 28158 26064 78926 2518 11745 ST LOUIS GALA 360750 360750 12954 18046 6598 2085990 2085990 28158 39018 96972 2518 18343 185009 -185009 1 BRIGHAM AND WOMEN'S HOSPITAL HBTM ROOM 6002P 60 FENWOOD RD BOSTON MA 02115 042312909 501(C)(3) 75000 DISCOVERY GRANT KECK SCHOOL OF MEDICINE OF UNIVERSITY OF SOUTHERN CALIFORNIA 346 N PALM DRIVE APT 2 BEVERLY HILLS CA 90210 951642394 501(C)(3) 50000 FELLOWSHIP THE MEDICAL COLLEGE OF WISCONSIN INC 8701 WATERTOWN PLANK ROAD MILWAUKEE WI 53226 390806261 501(C)(3) 100000 TRANSLATIONAL RESEARCH GRANT - 2ND YEAR NATIONAL HEART LUNG AND BLOOD INSTITUTE 10 CENTER DRIVE MSC 1454 BUILDING 10 MAGNUSON CC ROOM 5D-03 BETHESDA MD 20892 520858115 75000 DISCOVERY GRANT NEW YORK UNIVERSITY 435 EAST 30TH ST SCIENCE BUILDING RM 414 NEW YORK NY 10016 135562308 501(C)(3) 75000 DISCOVERY GRANT NEW YORK UNIVERSITY SCHOOL OF MEDICINE 151 E 31ST ST APT 20K NEW YORK NY 10016 135562308 501(C)(3) 50000 EARLY CAREER RESEARCH GRANT NEW YORK UNIVERSITY SCHOOL OF MEDICINE 301 E17TH ST ROOM 1608 NEW YORK NY 10003 135562308 501(C)(3) 100000 PSORIATIC ARTHRITIS DIAGNOSTIC TEST GRANT NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES 5601 FISHERS LN STE 6D MSC 980 ROCKVILLE MD 20852 520858115 100000 NIH-NPF FELLOWSHIP - 1ST YEAR NORTHWESTERN UNIVERSITY 676 N SAINT CLAIR STREET SUITE 1600 1600 CHICAGO IL 60611 362167817 501(C)(3) 50000 FELLOWSHIP UNIVERSITY HOSPITALS 11100 EUCLID AVENUE BOLWELL SUITE 3100 CLEVELAND OH 44106 341567805 501(C)(3) 50000 FELLOWSHIP UNIVERSITY OF CALIFORNIA SAN FRANCISCO 2340 SUTTER ST BOX 0808 N426 SAN FRANCISCO CA 94143 946036493 501(C)(3) 100000 PSORIATIC ARTHRITIS DIAGNOSTIC TEST GRANT UNIVERSITY OF CALIFORNIA DAVIS 2425 STOCKTON BOULEVARD SACRAMENTO CA 95617 946036494 501(C)(3) 100000 BRIDGE GRANT UNIVERSITY OF CALIFORNIA DAVIS PO BOX 989062 WEST SACRAMENTO CA 95798 946036494 501(C)(3) 100000 PSORIATIC ARTHRITIS DIAGNOSTIC TEST GRANT UNIVERSITY OF CALIFORNIA DAVIS 3301 C STREET SUITE 1400 SACRAMENTO CA 95816 946036494 501(C)(3) 50000 FELLOWSHIP UNIVERSITY OF CALIFORNIA DAVIS 1 SHIELDS AVENUE DAVIS CA 95619 946036494 501(C)(3) 100000 TRANSLATIONAL RESEARCH GRANT - 2ND YEAR UNIVERSITY OF CALIFORNIA LOS ANGELES PO BOX 957089 1125 MURPHY HALL 405 HILGARD AVENUE LOS ANGELES CA 90095 956006143 501(C)(3) 100000 BRIDGE GRANT UNIVERSITY OF CINCINNATI 231 ALBERT SABIN WAY MSB 3408 CINCINATTI OH 45267 316000989 501(C)(3) 75000 DISCOVERY GRANT REGENTS OF THE UNIVERSITY OF MICHIGAN 7412 MEDICAL SCIENCE I 1301 E CATHERINE ST ANN ARBOR MI 48109 386006309 501(C)(3) 75000 DISCOVERY GRANT TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA 3400 CIVER CENTER BLVD PCAM SOUTH TOWER 7TH FLOOR OFFICE 775 PHILADELPHIA PA 19104 231352685 501(C)(3) 50000 FELLOWSHIP UNIVERSITY OF PITTSBURGH 200 LOTHROP ST BST W1048 PITTSBURGH PA 15261 250965591 501(C)(3) 75000 DISCOVERY GRANT UNIVERSITY OF PITTSBURGH 200 LOTHROP ST W1028-3A BST PITTSBURGH PA 15217 250965591 501(C)(3) 50000 EARLY CAREER RESEARCH GRANT UNIVERSITY OF ROCHESTER 601 ELMWOOD AVE BOX 695 ROCHESTER NY 14642 160743209 501(C)(3) 100000 PSORIATIC ARTHRITIS DIAGNOSTIC TEST GRANT UNIVERSITY OF UTAH 30 N 1900 E DEPARTMENT OF DERMATOLO Y SALT LAKE CITY UT 84132 876000525 501(C)(3) 100000 PSORIATIC ARTHRITIS DIAGNOSTIC TEST GRANT 21 2 PART I, LINE 2: GRANT RECIPIENTS WITH MULTI-YEAR AWARDS PROVIDE INTERIM SCIENTIFIC AND FISCAL PROGRESS REPORTS. ALL GRANT RECIPIENTS PROVIDE A FINAL SCIENTIFIC REPORT AND ACCOUNTING AT THE CONCLUSION OF THE RESEARCH TERM. THE INTERIM AND FINAL REPORTS ARE REVIEWED BY THE SENIOR VP OF RESEARCH PROGRAMS OF THE NATIONAL PSORIASIS FOUNDATION. X X X X 1 1 0 1 0 1 0 1 0 RANDY BERANEK PRESIDENT/CEO 278122 0 30900 0 0 0 14000 0 14903 0 337925 0 0 0 LEAH HOWARD CHIEF OPERATING OFFICER 192800 0 10000 0 0 0 10140 0 10693 0 223633 0 0 0 EMILY BOYD CHIEF REVENUE OFFICER 180572 0 10000 0 0 0 9527 0 10270 0 210369 0 0 0 STACY BELL VP OF RESEARCH & MEDICAL AFFAIRS 185000 0 5000 0 0 0 8769 0 18347 0 217116 0 0 0 BRIDGET HART DIRECTOR OF MAJOR GIFTS 131333 0 0 0 0 0 6567 0 13341 0 151241 0 0 0 PART I, LINES 4A-B CHANGE OF CONTROL PAYMENT: DENICE BRADBURY - $44,250 THE CHANGE OF CONTROL PAYMENT WAS INITIATED AFTER THE EMPLOYEE SEPARATED. EMPLOYER CONTRIBUTIONS TO 401K: RANDY BERANEK - $14,000 LEAH HOWARD - $10,140 EMILY BOYD - $9,527 STACY BELL - $8,769 BRIDGET HART - $6,567 PATRICK STONE - $6,149 KRISTINE BOCKMIER - $5,892 DENICE BRADBURY - $5,340 PART I, LINE 5 THE EXECUTIVE TEAM PERFORMANCE-BASED BONUS PORTION OF THE COMPENSATION WAS BASED ON A COMBINATION OF THE EMPLOYEE'S PERFORMANCE AGAINST THEIR INDIVIDUAL OBJECTIVES (50%), THE NPF MEETING ITS ANNUAL REVENUE TARGET (25%) AND THE NPF MEETING ITS NET SURPLUS TARGET (25%). ALL STAFF ARE INCLUDED IN THE INCENTIVE PLAN AT 2% BASED ON REVENUE AND 2% BASED ON NET SURPLUS. PART I, LINE 6 THE EXECUTIVE TEAM PERFORMANCE-BASED BONUS PORTION OF THE COMPENSATION WAS BASED ON A COMBINATION OF THE EMPLOYEE'S PERFORMANCE AGAINST THEIR INDIVIDUAL OBJECTIVES (50%), THE NPF MEETING ITS ANNUAL REVENUE TARGET (25%) AND THE NPF MEETING ITS NET SURPLUS TARGET (25%). ALL STAFF ARE INCLUDED IN THE INCENTIVE PLAN AT 2% BASED ON REVENUE AND 2% BASED ON NET SURPLUS. PART I, LINE 7 THE EXECUTIVE TEAM PERFORMANCE-BASED BONUS PORTION OF THE COMPENSATION WAS BASED ON A COMBINATION OF THE EMPLOYEE'S PERFORMANCE AGAINST THEIR INDIVIDUAL OBJECTIVES (50%), THE NPF MEETING ITS ANNUAL REVENUE TARGET (25%) AND THE NPF MEETING ITS NET SURPLUS TARGET (25%). ALL STAFF ARE INCLUDED IN THE INCENTIVE PLAN AT 2% BASED ON REVENUE AND 2% BASED ON NET SURPLUS. X 3 766114 SALE PRICE 0 1 1 PART I, LINE 32B: THE ORGANIZATION USES AN OUTSIDE COMPANY THAT RECEIVES DONATED AUTOMOBILES AND SELLS THEM ON BEHALF OF THE ORGANIZATION. FORM 990, PART VI, SECTION B, LINE 11B THE FORM 990 IS EMAILED TO ALL BOARD MEMBERS FOR THEIR REVIEW PRIOR TO ITS BEING FILED ELECTRONICALLY WITH THE IRS. FORM 990, PART VI, SECTION B, LINE 12C WE HAVE A CONFLICT OF INTEREST POLICY THAT IS SIGNED BY ALL DIRECTORS ANUALLY. ALL DIRECTORS AND KEY EMPLOYEES REFRAIN FROM VOTING OR COMMENTING ON ANYTHING WHERE THERE COULD BE A CONFLICT. FORM 990, PART VI, SECTION B, LINE 15 THE BOARD OF DIRECTORS ANNUALLY REVEIWS AND APPROVES THE CEO'S COMPENSATION. THE FOUNDATION UTILIZES AN INDEPENDENT COMPENSATION CONSULTANT AND SUBSCRIBES TO A SALARY SURVEY FOR COMPARABLE INFORMATION FOR SALARIES. FORM 990, PART VI, SECTION C, LINE 19 GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, AND FINANCIAL STATEMENTS ARE AVAILABLE UPON REQUEST. AUDTIED FINANCIAL STATEMENTS ARE ALSO DISPLAYED ON THE WEBSITE. FORM 990, PART XII, LINE 2C THE PROCESS HAS NOT CHANGED FROM THE PRIOR YEAR.